Next report date
Report period
Q1 2024
EPS estimate
−0.28USD
Revenue estimate
—
−1.33USD
−33.97 MUSD
11.71 M
About Rani Therapeutics Holdings, Inc.
Sector
Industry
CEO
Talat Imran
Website
Headquarters
San Jose
Employees (FY)
140
Founded
2012
FIGI
BBG011R6PZ44
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RANI is 6.68 USD — it has increased by 1.83% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Rani Therapeutics Holdings, Inc. stocks are traded under the ticker RANI.
Rani Therapeutics Holdings, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
RANI stock is 6.44% volatile and has beta coefficient of −1.05. Check out the list of the most volatile stocks — is Rani Therapeutics Holdings, Inc. there?
RANI earnings for the last quarter are −0.36 USD per share, whereas the estimation was −0.43 USD resulting in a 15.49% surprise. The estimated earnings for the next quarter are −0.38 USD per share. See more details about Rani Therapeutics Holdings, Inc. earnings.
Yes, you can track Rani Therapeutics Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
RANI stock has risen by 15.97% compared to the previous week, the month change is a 120.46% rise, over the last year Rani Therapeutics Holdings, Inc. has showed a 48.78% increase.
RANI net income for the last quarter is −7.10 M USD, while the quarter before that showed −9.20 M USD of net income which accounts for 22.82% change. Track more Rani Therapeutics Holdings, Inc. financial stats to get the full picture.
Today Rani Therapeutics Holdings, Inc. has the market capitalization of 175.68 M, it has decreased by 2.41% over the last week.
No, RANI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RANI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rani Therapeutics Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has 140.00 employees. See our rating of the largest employees — is Rani Therapeutics Holdings, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Rani Therapeutics Holdings, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Rani Therapeutics Holdings, Inc. stock shows the buy signal. See more of Rani Therapeutics Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Rani Therapeutics Holdings, Inc. future price: according to them, RANI price has a max estimate of 12.00 USD and a min estimate of 7.00 USD. Read a more detailed Rani Therapeutics Holdings, Inc. forecast: see what analysts think of Rani Therapeutics Holdings, Inc. and suggest that you do with its stocks.